December 27, 2024

11 Medical Breakthroughs This Year

Explore medical breakthroughs from 2024, including advancements in Parkinson’s therapy, ulcerative colitis treatments, and gene therapy for hereditary deafness.

Conexiant

December 24, 2024

Merck to Halt Zinplava by January

Merck discontinuing Zinplava, an antibody drug designed to prevent the recurrence of a bacterial infection that can lead to fatal diarrhea, as disclosed on the FDA's website.

Reuters

December 23, 2024

Colonoscopy Prep: 48 Risk Factors Found

Study of 358,257 patients reveals Medicaid insurance and psychiatric disease predict poor colonoscopy preparation more strongly than traditionally assumed factors such as age or timing.

Conexiant

December 19, 2024

FDA Rejects New Bowel Disease Drug

The FDA declined to approve Zealand Pharma's bowel disease drug and sought an additional trial to confirm the drug's safety and efficacy, impacting thousands of adult patients in the United States.

Reuters

December 17, 2024

Teva Sanofi Drug Hits IBD Trial Goals

"These unprecedented results show that duvakitug could represent the next frontier in treating ulcerative colitis and Crohn’s disease."

Reuters

December 16, 2024

Probiotics' Limits Revealed in Major Review

"Current evidence does not support the notion that probiotics can restore the microbiota to its pre-antibiotic state."

Conexiant

December 16, 2024

Migraine Medicine May Help Gut Disorders

A genetic analysis published in Neurology Genetics revealed significant shared genetic connections between migraine and various gastrointestinal disorders, suggesting avenues for targeted treatment through the CGRP pathway.

Conexiant

December 16, 2024

Colon Cancer's Hidden Inflammatory Signature Found

Researchers have identified a significant breakdown in the body's natural inflammation-resolution process in colorectal cancer, where tumor cells maintain a chronic inflammatory state by failing to switch from pro-inflammatory to inflammation-resolving lipids, potentially opening new therapeutic pathways.

Conexiant

December 11, 2024

Colectomy Raises AKI, Kidney Failure Risk in IBD

A recent study has revealed that patients with inflammatory bowel disease face elevated risks of acute kidney injury and chronic kidney failure after undergoing colectomy, with certain factors increasing these risks. Read more about the study in Clinical Gastroenterology and Hepatology.

Conexiant